Fig. 4From: Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival modelOne-way sensitivity analysis of CUA of compared strategies in the first-line treatment of HR + / HER2- MBC using Tornado DiagramBack to article page